Apoptotic and necrotic cell death induced by death domain receptors

Cellular and Molecular Life Sciences

Volumn 58, Issue 3, 2001, Pages 356-370

  Denecker, G ^a   Vercammen, D ^a   Declercq, W ^a   Vandenabeele, P ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Apoptosis; Caspase; Death receptor; Mitochondria; Necrosis

Indexed keywords

APOPTOSIS INDUCING FACTOR; CALPAIN; CASPASE; CATHEPSIN; CYTOCHROME C; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE;

ANIMAL CELL; APOPTOSIS; BIOSENSOR; CELL DEATH; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN SECRETION; REVIEW;

ANIMALIA;

EID: 0035085627     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000863     Document Type: Review

References (201)

1. Programmed cell death in animal development
2. Cell death in development
3. Programmed cell death. II. Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths
4. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
5. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
6. Serotonin and octopamine in the nematode Caenorhabditis elegans
7. Genetic control of programmed cell death in the nematode C. elegans
8. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
9. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
10. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
11. The morphology of various types of cell death in prenatal tissues
12. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β PGE2, and PAF
13. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
14. A receptor for phosphatidylserine-specific clearance of apoptotic cells
15. Processing of engulfed apoptotic bodies yields T cell epitopes
16. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
17. Interleukin 1 is processed and released during apoptosis
18. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme
19. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
20. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
21. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine
22. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis
23. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7
24. Recognition and phagocytosis of cells undergoing apoptosis
25. Apoptosis: Phagocytic docking without shocking
26. Recognizing death: The phagocytosis of apoptotic cells
27. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
28. Apoptosis: The importance of being eaten
29. + suppresses the activation of apoptosis in lymphocytes
30. +, cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis
31. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
32. Molecular characterization of mitochondrial apoptosis-inducing factor
33. Acinus is a caspase-3-activated protein required for apoptotic chromatin
34. Condensed matter in cell death
35. Phosphatidylserine exposure during apoptosis precedes release of cytochrome c and decrease in mitochondrial transmembrane potential
36. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
37. The central effectors of cell death in the immune system
38. Identification of a new caspase homologue: Caspase-14
39. Catalytic properties of caspases
40. The proteolytic procaspase activation network: An in vitro analysis
41. Apoptosis by death factor
42. Transducing signals of life and death
43. Cell death in us and others
44. Tumor necrosis factor receptor and Fas signaling mechanisms
45. The modular nature of apoptotic signaling proteins
46. The domains of death: Evolution of the apoptosis machinery
47. Caspase activation: The induced-proximity model
48. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
49. Two CD95 (APO-1/Fas) signaling pathways
50. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
51. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
52. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
53. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
54. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
55. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes
56. The CARD domain: A new apoptotic signalling motif
57. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
58. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation
59. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis
60. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
61. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
62. The central role of the mitochondrial megachannel in apoptosis: Evidence obtained with intact cells, isolated mitochondria, and purified protein complexes
63. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux
64. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
65. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity
66. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
67. Structural and biochemical basis of apoptotic activation by Smac/DIABLO
68. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
69. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
70. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway
71. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1
72. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis
73. - efflux impairment in hematopoietic cell apoptosis
74. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes
75. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
76. Bcl-2 family proteins and mitochondria
77. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
78. BCL-2 family members and the mitochondria in apoptosis
79. Checkpoints of dueling dimers foil death wishes
80. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence
81. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria
82. L regulates the membrane potential and volume homeostasis of mitochondria
83. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
84. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis
85. Movement of Bax from the cytosol to mitochondria during apoptosis
86. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex
87. How BAD phosphorylation is good for survival
88. Viruses induce apoptosis in Bcl-2-overexpressing cells: Evidence for a caspase-mediated, proteolytic inactivation of Bcl-2
89. Cleavage of Bcl-2 is an early event in chemotherapy-induced apoptosis of human myeloid leukemia cells
90. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases
91. L through caspase interaction
92. Regulated targeting of BAX to mitochondria
93. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
94. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
95. The mitochondrial permeability transition
96. The permeability transition pore: Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death
97. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal
98. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals
99. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore
100. Perspectives on the mitochondrial multiple conductance channel
101. The equivalent pore radius of intact and damaged mitochondria and the mechanism of active shrinkage
102. The mitochondrial death/life regulator in apoptosis and necrosis
103. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy
104. The effect of X-rays on phosphorylation in vivo
105. Biochemical and morphological changes in lymphatic tissues following partial-body irradiation
106. The nature of the radiation-induced lesion of the electron transport chain of thymus mitochondria
107. The effect of lethal doses of X-irradiation on the enzymatic activity of mitochondrial cytochrome c
108. Apoptosis and necrosis: Intracellular ATP level as a determinant for cell death modes
109. Energy supply and the shape of death in neurons and lymphoid cells
110. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
111. Ultrastructural localization of cytochrome c in apoptosis demonstrates mitochondrial heterogeneity
112. Mitochondria and cell death: Mechanistic aspects and methodological issues
113. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
114. L prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange
115. Bcl-2 family proteins as ion-channels
116. Ion channel activity of the BH3 only Bcl-2 family member, BID
117. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death
118. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c
119. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease
120. Caspases: Their intracellular localization and translocation during apoptosis
121. Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis
122. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition
123. Caspase-independent programmed cell death with necrotic morphology
124. Interdigital cell death can occur through a necrotic and caspase-independent pathway
125. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: Evidence for apoptosis during selective neuronal loss
126. G-nitro-L-arginine methyl ester reduces necrotic but not apoptotic cell death induced by reversible focal ischemia in rat
127. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models
128. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure
129. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins
130. Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells
131. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis
132. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: Involvement of serine but not cysteine proteases
133. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis
134. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases
135. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent
136. m) and cytochrome c release are caspase independent
137. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway
138. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes
139. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons
140. Dual signaling of the Fas receptor: Initiation of both apoptotic and necrotic cell death pathways
141. Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects
142. Structure/function analysis of p55 tumor necrosis factor receptor and Fas-associated death domain: Effect on necrosis in L929sA cells
143. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor
144. More than one way to die: Apoptosis, necrosis and reactive oxygen damage
145. Caspase inhibitors
146. Caspase-independent cell killing by Fas-associated protein with death domain
147. Regulation of tumor necrosis factor-induced, mitochondria- and reactive oxygen species-dependent cell death by the electron flux through the electron transport chain complex I
148. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity
149. Redox regulation of TNF signaling
150. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions: Evidence for the involvement of mitochondrial radical generation
151. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF
152. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death
153. T-butyl-4-hydroxyanisole as an inhibitor of tumor cell respiration
154. Calpain and caspase: Can you tell the difference?
155. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases
156. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation
157. Cathepsin D protease mediates programmed cell death induced by interferon-gamma. Fas/APO-1 and TNF-alpha
158. Intracellular ATP, a switch in the decision between apoptosis and necrosis
159. Apoptosis without caspases: An inefficient molecular guillotine?
160. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases
161. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes. DNA damage, or the Bcl-2 homologue Bak
162. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death
163. Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers
164. Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells
165. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis
166. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1β-converting enzyme inhibition
167. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways
168. Bcl-2 prevents caspase-independent cell death
169. Resistance to the cytotoxic effects of tumor necrosis factor-α can be overcome by inhibition of a FADD/caspase-dependent signaling pathway
170. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli
171. Low levels of hydrogen peroxide and L-histidine induce DNA double-strand breakage and apoptosis
172. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis
173. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases
174. A comparative study of apoptosis and necrosis in HepG2 cells: Oxidant-induced caspase inactivation leads to necrosis
175. Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper
176. Mechanism of dithiocarbamate inhibition of apoptosis: Thiol oxidation by dithiocarbamate disulfides directly inhibits processing of the caspase-3 proenzyme
177. BCNU is a caspase-mediated inhibitor of drug-induced apoptosis
178. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
179. Nitric oxide inhibits CPP32-like activity under redox regulation
180. Suppression of neuronal apoptosis by S-nitrosylation of caspases
181. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
182. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide
183. S-nitrosylation regulates apoptosis
184. Nitric oxide inhibits APO-1/Fas-mediated cell death
185. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo
186. Fas-induced caspase denitrosylation
187. Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release
188. Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis
189. V. Necrapoptosis and the mitochondrial permeability transition: Shared pathways to necrosis and apoptosis
190. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis
191. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
192. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury
193. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis
194. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis: Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells
195. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
196. Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide
197. Expression level of Bcl-2 determines anti- or proapoptotic function
198. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax
199. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
200. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins
201. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells